The impressive €1.35bn ($1.5bn) sum that Forbion raised recently for its two newest funds demonstrates institutional investor belief in the sector, the European venture capital firm said, even while many public and private biotechs struggle as funding dries up.
Forbion Will Use New Fund To Rescue Struggling Biotechs
European VC Raises €1.35bn
The Netherlands and Germany-based VC firm wants to help out public and private companies who have undervalued late-stage assets and are struggling to raise new funds.
